Skip to main content
. 2016 Jan 6;41(1):52–59. doi: 10.1016/j.jgr.2015.12.011

Fig. 6.

Fig. 6

Potential mechanism underlying the beneficial action of the combined treatment with rosiglitazone (ROSI) and Korean Red Ginseng (KRG) on glucose regulation. KRG may enhance the glucose-lowering action of ROSI by reducing adipocyte size and macrophage recruitment in the adipose tissue of obese mice on a high-fat diet. AT, adipose tissue.